跳到主要内容
  • Sign in
    Welcome !
    My account
    Logout

SYNOVUS FINANCIAL CORP (SNV) Stock Forecast 2025 - AI Price Prediction & Analysis

SYNOVUS FINANCIAL CORP (SNV) AI Stock Price Forecast & Investment Analysis

SYNOVUS FINANCIAL CORP Stock Price Chart and Technical Analysis

Loading SYNOVUS FINANCIAL CORP interactive price chart and technical analysis...

SYNOVUS FINANCIAL CORP (SNV) - Comprehensive Stock Analysis & Investment Research

Deep dive into SYNOVUS FINANCIAL CORP's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about SYNOVUS FINANCIAL CORP, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For SYNOVUS FINANCIAL CORP: SYNOVUS FINANCIAL CORP operates in the Finance sector, establishing it as a mid-cap growth opportunity.

SYNOVUS FINANCIAL CORP (Stock Symbol: SNV) is a leading company in the Finance sector , specifically operating within the National Commercial Banks industry.

The organization employs approximately 4651 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing SYNOVUS FINANCIAL CORP's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For SYNOVUS FINANCIAL CORP: With $2783M in annual revenue and 59.8% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $2783 million generating a 59.8% net profit margin .

Market Capitalization: $7278 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): 16.0% - Excellent shareholder return efficiency, indicating strong management effectiveness.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for SYNOVUS FINANCIAL CORP stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For SYNOVUS FINANCIAL CORP: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for SYNOVUS FINANCIAL CORP stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: SYNOVUS FINANCIAL CORP's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For SYNOVUS FINANCIAL CORP: Strong free cash flow generation demonstrates solid operational efficiency.

SYNOVUS FINANCIAL CORP strategically competes in the highly dynamic National Commercial Banks marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company demonstrates robust operational efficiency through strong free cash flow generation of $931 million annually, complemented by impressive -97.3% year-over-year cash flow growth.

SYNOVUS FINANCIAL CORP (SNV) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for SYNOVUS FINANCIAL CORP stock analysis.

Loading SYNOVUS FINANCIAL CORP comprehensive fundamental analysis and insider trading data...

Deep dive into SYNOVUS FINANCIAL CORP's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if SYNOVUS FINANCIAL CORP stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For SYNOVUS FINANCIAL CORP: With a P/E ratio of 9.28, the market sees the stock as potentially undervalued.

P/E Ratio 9.28x
P/B Ratio 1.30x
Market Cap $7278M
Dividend Yield 2.99%
EPS $5.22
Book Value/Share $39.75
Revenue/Share $19.70
FCF/Share $0.03
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently SYNOVUS FINANCIAL CORP converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For SYNOVUS FINANCIAL CORP: An ROE of 16.0% demonstrates excellent shareholder value creation.

ROE 16.0%
ROA 1.3%
Net Margin 59.8%
EBT Margin 48.4%
Tax Rate 23.0%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess SYNOVUS FINANCIAL CORP's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For SYNOVUS FINANCIAL CORP:

D/E Ratio 0.19x
Financial Leverage 13.16x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal SYNOVUS FINANCIAL CORP's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For SYNOVUS FINANCIAL CORP: Free cash flow of $931M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $955M
Free Cash Flow $931M
Capital Spending $-25M
OCF Growth YoY -97.3%
FCF Growth YoY 15.5%
FCF/Sales 46.6%
CapEx/Sales 1.2%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively SYNOVUS FINANCIAL CORP uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For SYNOVUS FINANCIAL CORP: An asset turnover of 0.04x suggests room for improvement in asset utilization.

Asset Turnover 0.04x
Fixed Assets Turnover 4.7x
Understanding Financial Statement Data

What these metrics mean: Key figures from SYNOVUS FINANCIAL CORP's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For SYNOVUS FINANCIAL CORP: With annual revenue of $2783M, SYNOVUS FINANCIAL CORP operates at significant scale.

Income Statement ($ Millions)
Total Revenue $2783M
SG&A Expense $34M
Balance Sheet Highlights (% Of Assets)
Cash & Short-term Investments 21%
Total Liabilities 91%
Short-term Debt 4%
Accounts Receivable 0%
Dividend & Shareholder Information
Dividends Per Share $1.54
Payout Ratio 0.3%
Shares Outstanding 141M
Growth Metrics (YoY)
EPS Growth 4.1%

Latest SYNOVUS FINANCIAL CORP Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting SYNOVUS FINANCIAL CORP (SNV) stock price and investment outlook.

📰 We are currently updating our news feed for SYNOVUS FINANCIAL CORP. Check back soon for the latest market analysis and company updates.

SYNOVUS FINANCIAL CORP Competitors & Peer Analysis - Finance Sector

Comparative analysis of SYNOVUS FINANCIAL CORP against industry peers and competitors in the Finance sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ALRS Unlock Forecast - 30 Days FREE Trial $580M 15.0x 1.1x
AMJB Unlock Forecast - 30 Days FREE Trial $84691M 1.5x 0.2x
AMTB Unlock Forecast - 30 Days FREE Trial $886M 241.1x 1.0x
AROW Unlock Forecast - 30 Days FREE Trial $487M 15.9x 1.2x
ASRV Unlock Forecast - 30 Days FREE Trial $47M 12.8x 0.4x
ATLO Unlock Forecast - 30 Days FREE Trial $180M 13.1x 0.9x
BAC Unlock Forecast - 30 Days FREE Trial $386562M 13.8x 1.3x
BAC-PB Unlock Forecast - 30 Days FREE Trial $196790M 7.0x 0.7x
BAC-PE Unlock Forecast - 30 Days FREE Trial $165328M 5.9x 0.6x
BAC-PK Unlock Forecast - 30 Days FREE Trial $195170M 7.0x 0.7x
BAC-PL Unlock Forecast - 30 Days FREE Trial $9748114M 347.2x 32.5x
BAC-PM Unlock Forecast - 30 Days FREE Trial $176664M 6.3x 0.6x
BAC-PN Unlock Forecast - 30 Days FREE Trial $163400M 5.8x 0.6x
BAC-PO Unlock Forecast - 30 Days FREE Trial $144045M 5.1x 0.5x
BAC-PP Unlock Forecast - 30 Days FREE Trial $135254M 4.8x 0.5x
BAC-PQ Unlock Forecast - 30 Days FREE Trial $139573M 5.0x 0.5x
BAC-PS Unlock Forecast - 30 Days FREE Trial $155304M 5.5x 0.5x
BACRP Unlock Forecast - 30 Days FREE Trial $1912378M 68.1x 6.4x
BANC Unlock Forecast - 30 Days FREE Trial $2756M 18.7x 0.8x
BANC-PF Unlock Forecast - 30 Days FREE Trial $4101M 27.8x 1.2x
BANF Unlock Forecast - 30 Days FREE Trial $4526M 19.4x 2.6x
BANFP Unlock Forecast - 30 Days FREE Trial $882M 3.8x 0.5x
BCAL Unlock Forecast - 30 Days FREE Trial $530M 30.0x 1.0x
BFC Unlock Forecast - 30 Days FREE Trial $1273M 18.4x 2.1x
BHRB Unlock Forecast - 30 Days FREE Trial $937M 9.0x 1.2x
BML-PG Unlock Forecast - 30 Days FREE Trial $159313M 5.7x 0.5x
BML-PH Unlock Forecast - 30 Days FREE Trial $158388M 5.6x 0.5x
BML-PJ Unlock Forecast - 30 Days FREE Trial $164711M 5.9x 0.6x
BML-PL Unlock Forecast - 30 Days FREE Trial $159853M 5.7x 0.5x
BOKF Unlock Forecast - 30 Days FREE Trial $8507M 15.9x 1.4x
C Unlock Forecast - 30 Days FREE Trial $186034M 13.1x 0.9x
CAC Unlock Forecast - 30 Days FREE Trial $687M 14.0x 1.1x
CARE Unlock Forecast - 30 Days FREE Trial $445M 14.2x 1.1x
CASH Unlock Forecast - 30 Days FREE Trial $1858M 10.8x 2.4x
CBNA Unlock Forecast - 30 Days FREE Trial $201M x 1.3x
CBNK Unlock Forecast - 30 Days FREE Trial $575M 13.3x 1.5x
CBU Unlock Forecast - 30 Days FREE Trial $3127M 16.1x 1.7x
CFBK Unlock Forecast - 30 Days FREE Trial $156M 8.6x 0.9x
CFR Unlock Forecast - 30 Days FREE Trial $8109M 13.3x 1.9x
CFR-PB Unlock Forecast - 30 Days FREE Trial $1194M 2.0x 0.3x
CHCO Unlock Forecast - 30 Days FREE Trial $1834M 15.0x 2.4x
CMA Unlock Forecast - 30 Days FREE Trial $9141M 12.6x 1.3x
COF Unlock Forecast - 30 Days FREE Trial $142887M 16.5x 1.3x
COF-PI Unlock Forecast - 30 Days FREE Trial $12982M x 0.1x
COF-PJ Unlock Forecast - 30 Days FREE Trial $12515M x 0.1x
COF-PK Unlock Forecast - 30 Days FREE Trial $12049M x 0.1x
COF-PL Unlock Forecast - 30 Days FREE Trial $11383M x 0.1x
COF-PN Unlock Forecast - 30 Days FREE Trial $11332M x 0.1x
C-PN Unlock Forecast - 30 Days FREE Trial $58067M 4.1x 0.3x
DCOM Unlock Forecast - 30 Days FREE Trial $1354M 30.7x 1.0x
DCOMG Unlock Forecast - 30 Days FREE Trial $1154M 26.2x 0.8x
DCOMP Unlock Forecast - 30 Days FREE Trial $860M 19.5x 0.6x
ENBP Unlock Forecast - 30 Days FREE Trial $112M 6.5x 0.8x
EVBN Unlock Forecast - 30 Days FREE Trial $220M 15.2x 1.2x
FBMS Unlock Forecast - 30 Days FREE Trial $199M 15.3x 0.2x
FCF Unlock Forecast - 30 Days FREE Trial $1844M 13.8x 1.2x
FDBC Unlock Forecast - 30 Days FREE Trial $254M 10.7x 1.2x
FFBC Unlock Forecast - 30 Days FREE Trial $2507M 10.5x 1.0x
FHN Unlock Forecast - 30 Days FREE Trial $12151M 14.4x 1.4x
FHN-PB Unlock Forecast - 30 Days FREE Trial $13392M 15.9x 1.5x
FHN-PC Unlock Forecast - 30 Days FREE Trial $13545M 16.1x 1.5x
FHN-PE Unlock Forecast - 30 Days FREE Trial $13250M 15.7x 1.5x
FHN-PF Unlock Forecast - 30 Days FREE Trial $9965M 11.8x 1.1x
FIISO Unlock Forecast - 30 Days FREE Trial $2638M x 4.4x
FISI Unlock Forecast - 30 Days FREE Trial $557M 8.1x 0.9x
FLIC Unlock Forecast - 30 Days FREE Trial $269M 14.8x 0.7x
FMCB Unlock Forecast - 30 Days FREE Trial $759M 8.4x 1.2x
FNB Unlock Forecast - 30 Days FREE Trial $5940M 12.7x 0.9x
FNLC Unlock Forecast - 30 Days FREE Trial $303M 10.1x 1.1x
FRME Unlock Forecast - 30 Days FREE Trial $2344M 10.4x 1.0x
FRMEP Unlock Forecast - 30 Days FREE Trial $1499M 6.6x 0.6x
FSUN Unlock Forecast - 30 Days FREE Trial $1083M 12.2x 1.0x
FULT Unlock Forecast - 30 Days FREE Trial $3561M 11.0x 1.1x
FULTP Unlock Forecast - 30 Days FREE Trial $3697M 11.4x 1.1x
FUNC Unlock Forecast - 30 Days FREE Trial $240M 10.1x 1.3x
GNTY Unlock Forecast - 30 Days FREE Trial $569M 15.8x 1.7x
HAFC Unlock Forecast - 30 Days FREE Trial $753M 11.5x 1.0x
HBAN Unlock Forecast - 30 Days FREE Trial $26217M 12.4x 1.3x
HBANL Unlock Forecast - 30 Days FREE Trial $38360M 18.2x 1.8x
HBANM Unlock Forecast - 30 Days FREE Trial $34099M 16.2x 1.6x
HBANP Unlock Forecast - 30 Days FREE Trial $27864M 13.2x 1.3x
HOPE Unlock Forecast - 30 Days FREE Trial $1418M 34.0x 0.6x
HWBK Unlock Forecast - 30 Days FREE Trial $219M 10.6x 1.4x
JPM Unlock Forecast - 30 Days FREE Trial $844217M 14.9x 2.4x
JPM-PC Unlock Forecast - 30 Days FREE Trial $71770M 1.3x 0.2x
JPM-PD Unlock Forecast - 30 Days FREE Trial $71068M 1.3x 0.2x
JPM-PJ Unlock Forecast - 30 Days FREE Trial $59129M 1.1x 0.2x
JPM-PK Unlock Forecast - 30 Days FREE Trial $56349M 1.0x 0.2x
JPM-PL Unlock Forecast - 30 Days FREE Trial $57669M 1.0x 0.2x
JPM-PM Unlock Forecast - 30 Days FREE Trial $53034M 0.9x 0.2x
KEY Unlock Forecast - 30 Days FREE Trial $21283M 120.9x 1.1x
KEY-PI Unlock Forecast - 30 Days FREE Trial $27758M 157.7x 1.4x
KEY-PJ Unlock Forecast - 30 Days FREE Trial $24925M 141.6x 1.3x
KEY-PK Unlock Forecast - 30 Days FREE Trial $25002M 142.1x 1.3x
KEY-PL Unlock Forecast - 30 Days FREE Trial $27504M 156.3x 1.4x
LARK Unlock Forecast - 30 Days FREE Trial $158051M 9685.7x 1065.2x
LCNB Unlock Forecast - 30 Days FREE Trial $228M 10.8x 0.9x
MER-PK Unlock Forecast - 30 Days FREE Trial $199874M 7.1x 0.7x
MFG Unlock Forecast - 30 Days FREE Trial $17796M x 0.0x
MRBK Unlock Forecast - 30 Days FREE Trial $179M 9.8x 1.0x
MZHOF Unlock Forecast - 30 Days FREE Trial $82483M x 0.0x
NBHC Unlock Forecast - 30 Days FREE Trial $1469M 12.3x 1.1x
NBTB Unlock Forecast - 30 Days FREE Trial $2124M 15.9x 1.2x
NEWT Unlock Forecast - 30 Days FREE Trial $313M 5.9x 1.0x
NEWTG Unlock Forecast - 30 Days FREE Trial $651M 12.2x 2.1x
NEWTH Unlock Forecast - 30 Days FREE Trial $657M 12.3x 2.1x
NEWTI Unlock Forecast - 30 Days FREE Trial $655M 12.3x 2.1x
NEWTZ Unlock Forecast - 30 Days FREE Trial $657M 12.3x 2.1x
NIC Unlock Forecast - 30 Days FREE Trial $2099M 15.5x 1.8x
NKSH Unlock Forecast - 30 Days FREE Trial $198M 17.5x 1.2x
NWBI Unlock Forecast - 30 Days FREE Trial $1610M 11.2x 1.0x
OCFC Unlock Forecast - 30 Days FREE Trial $1059M 12.1x 0.6x
OCFCP Unlock Forecast - 30 Days FREE Trial $1460M 15.2x 0.9x
ONB Unlock Forecast - 30 Days FREE Trial $8812M 15.5x 1.1x
ONBPO Unlock Forecast - 30 Days FREE Trial $9882M 17.4x 1.2x
ONBPP Unlock Forecast - 30 Days FREE Trial $9897M 17.4x 1.2x
OPHC Unlock Forecast - 30 Days FREE Trial $52M 3.6x 0.5x
OPOF Unlock Forecast - 30 Days FREE Trial $215M 24.8x 1.8x
PFIS Unlock Forecast - 30 Days FREE Trial $533M 15.8x 1.1x
PNBK Unlock Forecast - 30 Days FREE Trial $0M -0.7x 0.0x
PNC Unlock Forecast - 30 Days FREE Trial $10M 16.6x 0.0x
PNFP Unlock Forecast - 30 Days FREE Trial $7576M 12.7x 1.1x
PNFPP Unlock Forecast - 30 Days FREE Trial $1934M 3.2x 0.3x
PRK Unlock Forecast - 30 Days FREE Trial $2753M 16.5x 2.3x
RF Unlock Forecast - 30 Days FREE Trial $24524M 11.8x 1.3x
RF-PC Unlock Forecast - 30 Days FREE Trial $21930M 10.6x 1.2x
RF-PE Unlock Forecast - 30 Days FREE Trial $16874M 8.1x 0.9x
RF-PF Unlock Forecast - 30 Days FREE Trial $23354M 11.2x 1.3x
SASR Unlock Forecast - 30 Days FREE Trial $1263M 19.2x 0.8x
SFNC Unlock Forecast - 30 Days FREE Trial $2593M 16.2x 0.7x
SFST Unlock Forecast - 30 Days FREE Trial $366M 16.8x 1.1x
SHBI Unlock Forecast - 30 Days FREE Trial $566M 10.5x 1.0x
SMBK Unlock Forecast - 30 Days FREE Trial $631M 15.1x 1.2x
SNV Unlock Forecast - 30 Days FREE Trial $7278M 9.3x 1.3x
SNV-PD Unlock Forecast - 30 Days FREE Trial $3606M 4.6x 0.6x
SNV-PE Unlock Forecast - 30 Days FREE Trial $3818M 4.9x 0.7x
STEL Unlock Forecast - 30 Days FREE Trial $1636M 14.9x 1.0x
TBBK Unlock Forecast - 30 Days FREE Trial $3615M 16.1x 4.2x
TFC Unlock Forecast - 30 Days FREE Trial $58585M -70.3x 4.1x
TRMK Unlock Forecast - 30 Days FREE Trial $2451M 11.3x 1.2x
UBFO Unlock Forecast - 30 Days FREE Trial $167M 14.9x 1.2x
UBOH Unlock Forecast - 30 Days FREE Trial $114M 10.1x 1.4x
UMBF Unlock Forecast - 30 Days FREE Trial $9262M 17.5x 1.3x
UMBFO Unlock Forecast - 30 Days FREE Trial $2017M 3.8x 0.3x
UMBFP Unlock Forecast - 30 Days FREE Trial $1898M x 0.3x
USB Unlock Forecast - 30 Days FREE Trial $77324M 11.2x 1.3x
USB-PA Unlock Forecast - 30 Days FREE Trial $1310739M 189.9x 21.3x
USB-PH Unlock Forecast - 30 Days FREE Trial $31983M 4.6x 0.5x
USB-PP Unlock Forecast - 30 Days FREE Trial $38505M 5.6x 0.6x
USB-PQ Unlock Forecast - 30 Days FREE Trial $25209M 3.7x 0.4x
USB-PR Unlock Forecast - 30 Days FREE Trial $26859M 3.9x 0.4x
USB-PS Unlock Forecast - 30 Days FREE Trial $31197M 4.5x 0.5x
VABK Unlock Forecast - 30 Days FREE Trial $218M 12.2x 1.3x
VLY Unlock Forecast - 30 Days FREE Trial $6034M 13.3x 0.8x
VLYPN Unlock Forecast - 30 Days FREE Trial $14931M 33.0x 2.0x
VLYPO Unlock Forecast - 30 Days FREE Trial $14221M 31.4x 1.9x
VLYPP Unlock Forecast - 30 Days FREE Trial $14480M 32.0x 1.9x
VYLD Unlock Forecast - 30 Days FREE Trial $74663M 1.3x 0.2x
WABC Unlock Forecast - 30 Days FREE Trial $1296M 10.2x 1.4x
WAFD Unlock Forecast - 30 Days FREE Trial $2542M 11.2x 0.8x
WAFDP Unlock Forecast - 30 Days FREE Trial $1400M 6.2x 0.5x
WBHC Unlock Forecast - 30 Days FREE Trial $2103M 33.3x 4.0x
WBS Unlock Forecast - 30 Days FREE Trial $10350M 12.1x 1.1x
WBS-PF Unlock Forecast - 30 Days FREE Trial $3431M 4.0x 0.4x
WBS-PG Unlock Forecast - 30 Days FREE Trial $4129M 4.8x 0.4x
WFC Unlock Forecast - 30 Days FREE Trial $267216M 13.0x 1.5x
WFCNP Unlock Forecast - 30 Days FREE Trial $5324M 0.3x 0.0x
WFC-PA Unlock Forecast - 30 Days FREE Trial $65190M 3.2x 0.4x
WFC-PC Unlock Forecast - 30 Days FREE Trial $60731M 3.0x 0.3x
WFC-PD Unlock Forecast - 30 Days FREE Trial $60232M 2.9x 0.3x
WFC-PL Unlock Forecast - 30 Days FREE Trial $4113064M 199.9x 22.7x
WFC-PY Unlock Forecast - 30 Days FREE Trial $82161M 4.0x 0.5x
WFC-PZ Unlock Forecast - 30 Days FREE Trial $66089M 3.2x 0.4x
WSBC Unlock Forecast - 30 Days FREE Trial $3060M 22.6x 0.8x
WSBCP Unlock Forecast - 30 Days FREE Trial $2416M 17.9x 0.6x
WSFS Unlock Forecast - 30 Days FREE Trial $3252M 12.2x 1.2x
ZION Unlock Forecast - 30 Days FREE Trial $8399M 10.0x 1.3x
ZIONL Unlock Forecast - 30 Days FREE Trial $3693M 5.8x 0.6x
ZIONO Unlock Forecast - 30 Days FREE Trial $3699M 5.8x 0.6x
ZIONP Unlock Forecast - 30 Days FREE Trial $3395M 4.0x 0.5x

Frequently Asked Questions - SYNOVUS FINANCIAL CORP Stock Forecast

How accurate are SYNOVUS FINANCIAL CORP stock predictions?

Our AI model demonstrates 64% historical accuracy for SNV predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence SYNOVUS FINANCIAL CORP stock price forecasts?

Our analysis considers SYNOVUS FINANCIAL CORP's financial metrics, Finance sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is SYNOVUS FINANCIAL CORP a good investment in 2025?

Based on our AI analysis, SYNOVUS FINANCIAL CORP shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are SYNOVUS FINANCIAL CORP forecasts updated?

SYNOVUS FINANCIAL CORP stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced SYNOVUS FINANCIAL CORP Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for SYNOVUS FINANCIAL CORP stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...